Revvity (RVTY) Short-term Investments (2023 - 2024)

Revvity's (RVTY) quarterly Short-term Investments came in at $706.1 million in Q2 2024, down 4.46% YoY from $739.1 million in Q3 2023, and up 1.25% on a QoQ basis from $697.3 million in Q1 2024.

Revvity (RVTY) Short-term Investments (2023 - 2024) Analysis & Trends

Revvity (RVTY) has 2 years of Short-term Investments data on file, last reported at $706.1 million in Q2 2024.

  • Quarterly Short-term Investments fell 4.46% year-over-year to $706.1 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $706.1 million (down 4.46% YoY) and the FY2023 annual result came in at $689.9 million, changed N/A from the prior year.
  • Short-term Investments rose to $706.1 million in Q2 2024, from $697.3 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $739.1 million in Q3 2023 to a low of $194.0 million in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn
10 Revvity 12.89 Bn 12.03 Bn 387.66 Mn

Historic Data

Download Data
DateValue
Jun 30, 2024 706.07 Mn
Mar 31, 2024 697.33 Mn
Dec 31, 2023 689.92 Mn
Oct 1, 2023 292.97 Mn
Jul 2, 2023 739.06 Mn
Apr 2, 2023 193.96 Mn